In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans

The fungal Cyp51-specific inhibitors VT-1161 and VT-1598 have emerged as promising new therapies to combat fungal infections, including Candida spp. To evaluate their in vitro activities compared to other azoles, MICs were determined by Clinical and Laboratory Standards Institute (CLSI) method for V...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Antimicrob Agents Chemother
Egile Nagusiak: Nishimoto, Andrew T., Wiederhold, Nathan P., Flowers, Stephanie A., Zhang, Qing, Kelly, Steven L., Morschhäuser, Joachim, Yates, Christopher M., Hoekstra, William J., Schotzinger, Robert J., Garvey, Edward P., Rogers, P. David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2019
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535515/
https://ncbi.nlm.nih.gov/pubmed/30910896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00341-19
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak